Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive Accelerated Intermittent Theta Burst Stimulation in Treatment-resistant Depression: A Multicenter, Randomized, Double-blind, Placebo Parallel Controlled Trial

NCT06166082 is registered in ClinicalTrials.gov with Changping Laboratory as lead sponsor.

NCT NCT06166082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06166082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive Accelerated Intermittent Theta Burst Stimulation in Treatment-resistant Depression: A Multicenter, Randomized, Double-blind, Placebo Parallel Controlled Trial
Lead sponsor
Changping Laboratory
Phase
Not applicable
Overall status
Completed
Start date
December 22, 2023
Completion date
April 21, 2025
Enrollment
130 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression